The company will use the funds to enrich its technology, commercialize its MRD product and continue the development of its multi-cancer early detection offering.
Adela scores $48M to grow genomic cancer detection platform
The company will use the funds to enrich its technology, commercialize its MRD product and continue the development of its multi-cancer early detection offering.
